In this blog, we review some of the main targets of universal vaccines and the key challenges to their successful implementation.
Browsing: Influenza Virus
A mouse study has revealed that obesity may be one factor explaining the significant amount of variation in the influenza virus each year, likely due to an impaired interferon defense response.
Crawford Kilian tells us about how he got into the world of flu blogging, or ‘Flublogia’ and what he’s learnt from his experiences with this world over the last 15 years.
A study has evaluated de-identified data from wearable devices, discovering that this could improve real-time prediction of flu-like illnesses when compared with current surveillance methods.
The first strain of flu we encounter during childhood could impact our immune responses to future infections, according to new research.
Two analyses supported by the Centers for Disease Control and Prevention’s US influenza data have demonstrated that immunization reduces the risk of hospitalization in children and death in adults
US FDA approves RECARBRIO™ for complicated UTIs and complicated intra-abdominal infections: July’s industry headlines
Take a look at this month’s industry headlines including a US FDA approval for RECARBRIO™, positive results for XOFLUZA in children and new ACIP recommendations.
Research presented at ECCMID examining influenza transmission has discovered that a substantial proportion of patients and healthcare workers shed the flu virus before clinical symptoms appear.
The WHO has released a Global Influenza Strategy for 2019–2030 aiming to prevent seasonal flu, prepare for a pandemic situation and control the spread of zoonotic influenza.
Collaborative research efforts with scientists from Janssen, the Scripps Research Institute, the University of Hong Kong, the University of Pennsylvania and more has led to success in creating a promising novel long-lasting llama-derived antibody therapy for influenza.